Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Alzheimer's Research & Therapy 10 (2018).
- Schlagwort
-
-
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2018
- Urheber
-
Lewczuk, Piotr
Gaignaux, Amélie
Kofanova, Olga
Ermann, Natalia
Betsou, Fay
Brandner, Sebastian
Mroczko, Barbara
Blennow, Kaj
Strapagiel, Dominik
Paciotti, Silvia
Vogelgsang, Jonathan
Roehrl, Michael H.
Mendoza, Sandra
Kornhuber, Johannes
Teunissen, Charlotte
- URN
-
urn:nbn:de:bvb:29-opus4-100637
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:46 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lewczuk, Piotr
- Gaignaux, Amélie
- Kofanova, Olga
- Ermann, Natalia
- Betsou, Fay
- Brandner, Sebastian
- Mroczko, Barbara
- Blennow, Kaj
- Strapagiel, Dominik
- Paciotti, Silvia
- Vogelgsang, Jonathan
- Roehrl, Michael H.
- Mendoza, Sandra
- Kornhuber, Johannes
- Teunissen, Charlotte
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2018
Ähnliche Objekte (12)
Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
Alzheimer’s Disease—Biochemical and Psychological Background for Diagnosis and Treatment
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Multiple Discriminant Analysis of SPECT Data for Alzheimer’s Disease, Frontotemporal Dementia and Asymptomatic Controls
Digit Ratio (2D:4D) Is Not Associated with Alzheimer’s Disease in the Elderly
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Imbalance of Circulating Th17 and Regulatory T Cells in Alzheimer’s Disease: A Case Control Study
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
Pulsed Arterial Spin Labeling and Segmented Brain Volumetry in the Diagnostic Evaluation of Frontotemporal Dementia, Alzheimer’s Disease and Mild Cognitive Impairment
Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
Alzheimer’s Disease—Biochemical and Psychological Background for Diagnosis and Treatment
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Multiple Discriminant Analysis of SPECT Data for Alzheimer’s Disease, Frontotemporal Dementia and Asymptomatic Controls
Digit Ratio (2D:4D) Is Not Associated with Alzheimer’s Disease in the Elderly
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Imbalance of Circulating Th17 and Regulatory T Cells in Alzheimer’s Disease: A Case Control Study
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
Pulsed Arterial Spin Labeling and Segmented Brain Volumetry in the Diagnostic Evaluation of Frontotemporal Dementia, Alzheimer’s Disease and Mild Cognitive Impairment
Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
Alzheimer’s Disease—Biochemical and Psychological Background for Diagnosis and Treatment
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Multiple Discriminant Analysis of SPECT Data for Alzheimer’s Disease, Frontotemporal Dementia and Asymptomatic Controls
Digit Ratio (2D:4D) Is Not Associated with Alzheimer’s Disease in the Elderly
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Imbalance of Circulating Th17 and Regulatory T Cells in Alzheimer’s Disease: A Case Control Study
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease